Related Experiment Video
Updated: Aug 29, 2026

Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface
Published on: February 21, 2011
Lung matrix metalloproteinase-9 correlates with cigarette smoking and obstruction of airflow
Min Jong Kang1, Yeon-Mok Oh, Jae Cheol Lee
1Department of Internal Medicine, Hallym University Sacred Heart Hospital, College of Medicine, Hallym University, Anyang, Korea.
Abstract:
Cigarette smoking is the most important risk factor for obstruction of airflow in chronic obstructive pulmonary disease (COPD). Matrix metalloproteinases (MMPs) or an imbalance between MMPs and their inhibitors, the tissue inhibitors of MMP (TIMPs), is considered to play a role in the pathogenesis of COPD. We investigated whether the MMPs expression or the imbalance between MMPs and TIMP-1 is associated with the amount of cigarette smoking and the FEV1 value, in the lung parenchyma of 26 subjects (6 non-smokers and 20 cigarette smokers). First, we performed zymographic analysis to identify the profile of the MMPs, which revealed gelatinolytic bands mainly equivalent to MMP-9 in the smokers. We then measured, using enzyme immunoassay, the concentrations of MMP-9 and its inhibitor, TIMP-1. Correlation analysis revealed that both the MMP-9 concentrations and the molar ratios of MMP-9 to TIMP-1 (MMP-9/TIMP-1) were correlated with the amount of cigarette smoking. Furthermore, MMP-9 concentrations were inversely correlated with FEV1. In conclusion, this study shows that MMP-9 expression in human lung parenchyma is associated with cigarette smoking and also with the obstruction of airflow, suggesting that MMP-9 may play a role in the pathogenesis of the cigarette smoke-induced obstruction of airflow known as the characteristic of COPD.
Insights
Matrix metalloproteinases (MMPs), specifically MMP-9, increase with cigarette smoking and correlate with reduced lung function (FEV1). This suggests MMP-9 plays a role in COPD pathogenesis, particularly in smokers.
Area of Science:
- Pulmonary Medicine
- Biochemistry
- Respiratory Research
Background:
- Cigarette smoking is a primary risk factor for Chronic Obstructive Pulmonary Disease (COPD).
- An imbalance in Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of MMPs (TIMPs) is implicated in COPD pathogenesis.
- MMP-9 and its inhibitor TIMP-1 are key players in tissue remodeling and inflammation.
Purpose of the Study:
- To investigate the association between MMP expression, MMP-9/TIMP-1 imbalance, smoking amount, and airflow obstruction (FEV1) in lung parenchyma.
- To determine the specific MMPs involved in the lung tissue of smokers versus non-smokers.
Main Methods:
- Zymographic analysis to identify MMP profiles in lung parenchyma.
- Enzyme immunoassay to quantify MMP-9 and TIMP-1 concentrations.
- Correlation analysis to link MMP-9/TIMP-1 levels with smoking history and FEV1 values.
Main Results:
- Zymography revealed MMP-9 as the predominant gelatinolytic enzyme in smokers' lung parenchyma.
- MMP-9 concentrations and MMP-9/TIMP-1 ratios significantly correlated with the amount of cigarette smoking.
- MMP-9 concentrations showed an inverse correlation with FEV1, indicating reduced airflow obstruction.
Conclusions:
- MMP-9 expression in human lung parenchyma is significantly associated with cigarette smoking.
- Elevated MMP-9 levels and altered MMP-9/TIMP-1 ratios are linked to airflow obstruction in COPD patients.
- MMP-9 is suggested to be a key mediator in the pathogenesis of COPD induced by cigarette smoke.
Related Concept Videos
Chronic Obstructive Pulmonary Disease II: Emphysema
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features